Wolverine Asset Management LLC Bridge Bio Pharma, Inc. Put Options Transaction History

Wolverine Asset Management LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 04, 2024	BUY	$23.91 - $31.3 $597,750 - $782,500	25,000 Added 65.62%	63,100 $1.61 Million
Q4 2023 Feb 01, 2024	BUY	$24.02 - $43.89 $915,162 - $1.67 Million	38,100 New	38,100 $1.54 Million
Q1 2022 May 04, 2022	SELL	$7.34 - $17.16 $7,340 - $17,160	-1,000 Closed	0 $0
Q4 2021 Feb 09, 2022	SELL	$11.38 - $53.41 $1.99 Million - $9.36 Million	-175,200 Reduced 99.43%	1,000 $16,000
Q3 2021 Nov 12, 2021	BUY	$46.87 - $64.24 $46,870 - $64,239	1,000 Added 0.57%	176,200 $8.26 Million
Q2 2021 Aug 13, 2021	BUY	$46.47 - $63.93 $3.25 Million - $4.48 Million	70,000 Added 66.54%	175,200 $10.7 Million
Q1 2021 May 13, 2021	BUY	$55.47 - $72.35 $1.4 Million - $1.82 Million	25,200 Added 31.5%	105,200 $6.48 Million
Q4 2020 Feb 12, 2021	BUY	$38.38 - $71.11 $3.07 Million - $5.69 Million	80,000 New	80,000 $5.69 Million

291

171M

10.4M

2.37M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.45B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Asset Management LLC with notifications on news.